Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Stark

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pathology|March 1, 1986
Biphenotypic leukaemiaA N Stark, C S Scott, R D Pyrah, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Diagnostic differentiation between reactive and malignant lymphoid cells in serous effusionsE J Johnson, C S Scott, L A Parapia, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal toxicity due to intermediate-dose methotrexateA N Stark, G Jackson, P J Carey, et al.
British Journal of Cancer|July 1, 1987
Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML)A N Stark, J Thorogood, C Head, et al.
Disease Markers|March 1, 1987
Serum enzyme and ferritin concentrations in acute leukaemiaA N Stark, K Gailor, P I Langdale, et al.
Blut|January 1, 1988
TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?A N Stark, I D MacKarill, H J Limbert, et al.
Clinical Endocrinology|December 1, 1982
Trilostane and the normal hypothalamic-pituitary-adrenocortical axisC G Semple, J A Thomson, A N Stark, et al.
Journal of Clinical Pathology|May 1, 1987
Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumoursR A Jones, C S Scott, D R Norfolk, et al.
Leukemia Research|January 1, 1986
Prolymphocytoid transformation of CLL: a clinical and immunological study of 22 casesA N Stark, H J Limbert, B E Roberts, et al.
British Journal of Haematology|June 1, 1988
Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 casesC S Scott, A N Stark, H J Limbert, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pathology|March 1, 1986
Biphenotypic leukaemiaA N Stark, C S Scott, R D Pyrah, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1987
Diagnostic differentiation between reactive and malignant lymphoid cells in serous effusionsE J Johnson, C S Scott, L A Parapia, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal toxicity due to intermediate-dose methotrexateA N Stark, G Jackson, P J Carey, et al.
British Journal of Cancer|July 1, 1987
Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML)A N Stark, J Thorogood, C Head, et al.
Disease Markers|March 1, 1987
Serum enzyme and ferritin concentrations in acute leukaemiaA N Stark, K Gailor, P I Langdale, et al.
Blut|January 1, 1988
TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?A N Stark, I D MacKarill, H J Limbert, et al.
Clinical Endocrinology|December 1, 1982
Trilostane and the normal hypothalamic-pituitary-adrenocortical axisC G Semple, J A Thomson, A N Stark, et al.
Journal of Clinical Pathology|May 1, 1987
Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumoursR A Jones, C S Scott, D R Norfolk, et al.
Leukemia Research|January 1, 1986
Prolymphocytoid transformation of CLL: a clinical and immunological study of 22 casesA N Stark, H J Limbert, B E Roberts, et al.
British Journal of Haematology|June 1, 1988
Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 casesC S Scott, A N Stark, H J Limbert, et al.
Pageof 3